HomeTYRA • NASDAQ
add
Tyra Biosciences Inc
Previous close
$10.07
Day range
$9.84 - $10.73
Year range
$6.42 - $29.60
Market cap
535.68M USD
Avg Volume
353.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.85M | 42.68% |
Net income | -28.15M | -54.72% |
Net profit margin | — | — |
Earnings per share | -0.47 | -34.29% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 343.48M | -15.14% |
Total liabilities | 19.94M | 34.18% |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -22.52% | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -28.15M | -54.72% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | -19.74M | -18.41% |
About
Founded
2018
Headquarters
Website
Employees
60
